HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 10, 2022 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Source: globenewswire.com
Kumar Vinay News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kumar Vinay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.